Anteilseigner
Renaissance Technologies LLC (1,43 %) G1 Execution Services LLC (1,12 %) Citadel Securities LLC (0,96 %) The Vanguard Group, Inc. (0,48 %) Tower Research Capital LLC (0,07 %) Albert D. Dyrness (0,04 %) John Harry Cross (0,04 %) Richard T. Kenney,
MD (0,03 %) BlackRock Fund Advisors (0,02 %) Donald J. Griffith (0,01 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,00 %) Securities America Advisors, Inc. (0,00 %) Wells Fargo Bank, NA (Private Banking) (0,00 %)
Kontakt
Sonnet Biotherapeutics Holdings Inc